WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 1.56 %Nav, as on 23-01-2025

  • Previous Nav

  • Net Change on 23-01-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI -2.12 1.04 31.49 21.61 25.84 15.97
BSE SENSEX - TRI -2.55 -4.28 10.07 10.40 14.44 13.44

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 21.35 19.23 25.77 1.80 8,914.89
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 34.34 23.90 28.58 1.91 5,320.29
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 29.60 22.95 27.55 1.94 3,628.03
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 31.20 21.89 27.95 1.90 3,339.79
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 26.95 17.64 26.57 1.92 2,863.52

Fund Holdings as on 31-December-2024

  • Sun Pharmaceutical Industries Limited

  • Clearing Corporation of India Ltd

  • Divi's Laboratories Limited

  • Cipla Limited

  • Lupin Limited

  • Max Healthcare Institute Limited

  • Fortis Healthcare Limited

  • Mankind Pharma Limited

  • Krishna Institute Of Medical Sciences Limited

  • Apollo Hospitals Enterprise Limited

  • Laurus Labs Limited

  • IPCA Laboratories Limited

  • Glenmark Pharmaceuticals Limited

  • Piramal Pharma Limited

  • Biocon Limited

  • Poly Medicure Limited

  • Ami Organics Limited

  • Aurobindo Pharma Limited

  • Ajanta Pharma Limited

  • Aster DM Healthcare Limited

  • Torrent Pharmaceuticals Limited

  • Neuland Laboratories Limited

  • Vijaya Diagnostic Centre Limited

  • Strides Pharma Science Limited

  • Sai Life Sciences Limited

  • Global Health Limited

  • Supriya Lifescience Limited

  • PB Fintech Limited

  • Kovai Medical Center and Hospital Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Shaily Engineering Plastics Limited

  • Onesource Specialty Pharma Limited **

  • Jupiter Life Line Hospitals Limited

  • 91 Days Tbill (MD 03/01/2025)

  • 182 Days Tbill (MD 14/02/2025)

  • Vimta Labs Limited

  • Eris Lifesciences Limited

  • Rainbow Childrens Medicare Limited

  • Dr. Reddy's Laboratories Limited

  • Blue Jet Healthcare Ltd

  • Shilpa Medicare Limited

  • Net Receivables / (Payables)

  • 364 Days Tbill (MD 30/01/2025)

  • 91 Days Tbill (MD 27/02/2025)

  • Gufic Biosciences Limited

  • Thyrocare Technologies Limited

  • Dr.Agarwals Eye Hospital Limited

  • MedPlus Health Services Limited

  • 364 Days Tbill (MD 23/01/2025)

  • 182 Days Tbill (MD 20/02/2025)

  • Zota Health Care Limited

  • 364 Days Tbill (MD 09/01/2025)

  • 91 Days Tbill (MD 28/03/2025)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

  • Fintech

  • Plastic Products

View More

Fund Manager

  • Cash

  • Equity

  • Sov

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹282.62 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended up ₹0.2(1.56%)yesterday to ₹13.184.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643